2qk8: Difference between revisions

Revision as of 18:32, 27 July 2008

This article has been automatically seeded. Changes to this page should pertain to the PDB entry only and not to the protein or biomolecule in general.

File:2qk8.png

Template:STRUCTURE 2qk8

Crystal structure of the anthrax drug target, Bacillus anthracis dihydrofolate reductaseCrystal structure of the anthrax drug target, Bacillus anthracis dihydrofolate reductase

Template:ABSTRACT PUBMED 17696333

About this StructureAbout this Structure

2QK8 is a Single protein structure of sequence from Bacillus anthracis. Full crystallographic information is available from OCA.

ReferenceReference

Crystal structure of the anthrax drug target, Bacillus anthracis dihydrofolate reductase., Bennett BC, Xu H, Simmerman RF, Lee RE, Dealwis CG, J Med Chem. 2007 Sep 6;50(18):4374-81. Epub 2007 Aug 14. PMID:17696333

Page seeded by OCA on Sun Jul 27 18:32:43 2008

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA

@@ Line 1: / Line 1: @@
-[[Image:2qk8.jpg|left|200px]]
+{{Seed}}
+[[Image:2qk8.png|left|200px]]
 <!--
@@ Line 9: / Line 10: @@
 {{STRUCTURE_2qk8|  PDB=2qk8  |  SCENE=  }}
-'''Crystal structure of the anthrax drug target, Bacillus anthracis dihydrofolate reductase'''
+===Crystal structure of the anthrax drug target, Bacillus anthracis dihydrofolate reductase===
-==Overview==
+<!--
-Spores of Bacillus anthracis are the infectious agent of anthrax. Current antibiotic treatments are limited due to resistance and patient age restrictions; thus, additional targets for therapeutic intervention are needed. One possible candidate is dihydrofolate reductase (DHFR), a biosynthetic enzyme necessary for anthrax pathogenicity. We determined the crystal structure of DHFR from B. anthracis (baDHFR) in complex with methotrexate (MTX; 1) at 2.4 Angstrom resolution. The structure reveals the crucial interactions required for MTX binding and a putative molecular basis for how baDHFR has natural resistance to trimethoprim (TMP; 2). The structure also allows insights for designing selective baDHFR inhibitors that will have weak affinities for the human enzyme. Additionally, we have found that 5-nitro-6-methylamino-isocytosine (MANIC; 3), which inhibits another B. anthracis folate synthesis enzyme, dihydropteroate synthase (DHPS), can also inhibit baDHFR. This provides a starting point for designing multi-target inhibitors that are less likely to induce drug resistance.
+The line below this paragraph, {{ABSTRACT_PUBMED_17696333}}, adds the Publication Abstract to the page
+(as it appears on PubMed at http://www.pubmed.gov), where 17696333 is the PubMed ID number.
+-->
+{{ABSTRACT_PUBMED_17696333}}
 ==About this Structure==
@@ Line 33: / Line 37: @@
 [[Category: Pseudo-rossman fold]]
 [[Category: Pteridine binding]]
-''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun May  4 15:06:22 2008''
+''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun Jul 27 18:32:43 2008''